Multilevel Barriers to HIV PrEP Uptake and Adherence Among Black and Hispanic/Latinx Transgender Women in Southern California
- 29 January 2021
- journal article
- research article
- Published by Springer Nature in AIDS and Behavior
- Vol. 25 (7) , 2301-2315
Abstract
Black and Hispanic/Latinx transgender women in the United States (U.S.) are disproportionately affected by HIV. Pre-exposure prophylaxis (PrEP) reduces risk of HIV infection but PrEP uptake remains low among Black and Hispanic/Latinx transgender women. Between July 2018 and August 2019, we conducted individual interviews with 30 Black and Hispanic/Latinx transgender women who were prescribed PrEP through a PrEP demonstration project and 10 healthcare providers who provide PrEP services to transgender women in Los Angeles and San Diego, California. The interviews assessed general attitudes, experiences, and beliefs about PrEP as well as individual-, interpersonal-, community-, and structural-level barriers to PrEP uptake and adherence. PrEP adherence was assessed by collecting quantitative intracellular tenofovir-diphosphate (TFV-DP) levels in retrospect on batched, banked dried blood spot (DBS) samples. We utilized qualitative content analysis to identify themes from the interviews. Findings indicated the presence of individual-level barriers including cost concerns, mental health issues, substance use, and concerns about PrEP side effects including hormone interaction. Interpersonal-level barriers included the influence of intimate/romantic partners and the impact of patient-provider communication. Community-level barriers consisted of experiencing stigma and negative community opinions about PrEP use as well as having negative experiences in healthcare settings. Structural-level barriers included unreliable transportation, employment, and housing insecurity. Interventions aiming to increase PrEP uptake and adherence among Black and Hispanic/Latinx transgender women in the U.S. should employ a multilevel approach to addressing the needs of transgender women, especially the structural barriers that have greatly limited the use of PrEP.Keywords
Funding Information
- National Institute on Drug Abuse (DA044073, DA043402)
- National Institute of Mental Health (MH58107)
- California HIV/AIDS Research Program (PR15-SD-021)
This publication has 36 references indexed in Scilit:
- Awareness, Interest, and HIV Pre-Exposure Prophylaxis Candidacy Among Young TranswomenAIDS Patient Care and STDs, 2016
- ‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender womenGlobal Public Health, 2016
- HIV pre-exposure prophylaxis in transgender women: a subgroup analysis of the iPrEx trialThe Lancet HIV, 2015
- HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV PreventionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2014
- HIV epidemics among transgender womenCurrent Opinion in HIV and AIDS, 2014
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010
- The PHQ-8 as a measure of current depression in the general populationJournal of Affective Disorders, 2009
- Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groupsInternational Journal for Quality in Health Care, 2007
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- An Ecological Perspective on Health Promotion ProgramsHealth Education Quarterly, 1988